Search Results - Alan H Fairlamb

The critical role of mode of action studies in kinetoplastid drug discovery by Alan H. Fairlamb, Susan Wyllie

Connect to this object online.

Trypanosoma brucei DHFR-TS Revisited: Characterisation of a Bifunctional and Highly Unstable Recombinant Dihydrofolate Reductase-Thymidylate Synthase. by Marc W Gibson, Simon Dewar, Han B Ong, Natasha Sienkiewicz, Alan H Fairlamb

Connect to this object online.

A static-cidal assay for Trypanosoma brucei to aid hit prioritisation for progression into drug discovery programmes. by Manu De Rycker, Sandra O'Neill, Dhananjay Joshi, Lorna Campbell, David W Gray, Alan H Fairlamb

Connect to this object online.

Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent? by Meghan R Perry, Susan Wyllie, Vijay Kumar Prajapati, Joerg Feldmann, Shyam Sundar, Marleen Boelaert, Alan H Fairlamb

Connect to this object online.

Genomic and Proteomic Studies on the Mode of Action of Oxaboroles against the African Trypanosome. by Deuan C Jones, Bernardo J Foth, Michael D Urbaniak, Stephen Patterson, Han B Ong, Matthew Berriman, Alan H Fairlamb

Connect to this object online.

Arsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India: a retrospective cohort study. by Meghan R Perry, Vijay K Prajapati, Joris Menten, Andrea Raab, Joerg Feldmann, Dipankar Chakraborti, Shyam Sundar, Alan H Fairlamb, Marleen Boelaert, Albert Picado

Connect to this object online.